Fred Aslan

Fred Aslan is a Vice President at Venrock, a premier venture capital firm with over 40 years of investing history. At Venrock, Fred specializes in the health care industry, having made a number of investments in medical technology companies. Fred is also founder and CEO of ADVANCE Medical, a Venrock-backed portfolio company initially created to commercialize innovative medical technology in Brazil and other countries in Latin America. Prior to Venrock, Fred was Director of Business Development at CuraGen Corporation, a cancer-focused therapeutics company. Prior to CuraGen, Fred worked at the Boston Consulting Group where he advised healthcare companies on a number of strategic issues. Fred received his B.S. in Biology from Duke University, his M.D. from Yale University and his M.B.A. from Harvard University.